Explore 3 Stock Ideas & Industry Insights Download Free Report

Company price
0.0022 GBX -0.22 ( 99.02%)
Last update at 2026-10-23T07:00:00Z
Market Cap
1.42M

Momentum Score

…

Kanabo Group Plc, a digital health company, engages in the research, development and commercialization of cannabis-derived formulations and therapeutic inhalation devices. It operates through Primary Care and Secondary Care segments. The company offers The GP Service, an online telehealth platform, that provides patients with video consultations, online prescriptions, and primary care services; and operates Treat It, an online clinic focused on management of chronic pain. It also provides cultivation consultancy for cannabis businesses, as well as develops and distributes cannabis derived medicinal and wellness products. Kanabo Group Plc was incorporated in 2016 and is based in London, the United Kingdom.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.00
Low
0.00
High
52 Week Price Range
0.20
Low
0.35
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
0.23
Dividend Yield
-
Revenue TTM
1.14M
Revenue Per Share
0.00
Gross Profit TTM
0.09M
Debt / Equity
0.04
ROE
-83.19%
Net Debt
-1.41M
ROCE
-103.69%
Diluted EPS TTM
-0.01

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Income before tax -8.00M -6.87M -4.55M -0.13M -0.36M
Minority interest 0.01M 0.00M - - -
Net income -7.99M -8.00M -8.07M -0.11M -0.36M
Selling general administrative 0.80M 1.36M 0.86M 0.12M 0.36M
Selling and marketing expenses 0.31M 0.44M 0.16M - -
Gross profit 0.13M 0.20M 0.01M - -
Reconciled depreciation 1.45M 1.18M 0.01M - -
Ebit -7.92M -5.39M -2.80M -0.16M -0.36M
Ebitda -6.47M -4.51M -1.03M -0.16M -0.36M
Depreciation and amortization 1.45M 0.89M 1.78M - -
Operating income -7.79M -5.39M -2.80M -0.16M -0.36M
Other operating expenses 8.69M 6.00M 2.88M 0.16M 0.36M
Interest expense 0.07M 0.06M 0.02M 0.00M 0.00M
Tax provision 0.00M - 0.00M 0.00M 0.00M
Interest income 0.02M 0.00M 0.02M 0.03M 0.00M
Net interest income -0.05M -0.07M 0.02M 0.03M 0.00M
Income tax expense -0.21M 1.13M 3.52M -0.03M -0.00M
Total revenue 0.90M 0.60M 0.07M 0.00M -
Total operating expenses 7.93M 5.59M 2.81M 0.16M 0.36M
Cost of revenue 0.76M 0.40M 0.07M - -
Total other income expense net -0.20M -1.48M -1.75M 0.03M 0.00M
Net income from continuing ops -8.00M -6.87M -4.55M -0.13M -0.36M
Net income applicable to common shares - - -4.55M -0.13M -0.36M
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 8.35M 14.45M 5.60M 0.79M 0.71M
Intangible assets 4.73M 5.99M - - -
Other current assets 0.08M - 0.27M 0.43M 0.01M
Total liab 0.85M 2.01M 0.41M 0.05M 0.04M
Total stockholder equity 7.51M 12.45M 5.18M 0.74M 0.67M
Other current liab 0.41M 1.15M 0.38M 0.04M 0.02M
Common stock 15.81M 10.57M 9.25M 0.73M 0.73M
Capital stock 15.81M 10.57M 9.25M 0.73M 0.73M
Retained earnings -20.72M -13.61M -6.75M -0.78M -0.71M
Good will 0.00M 4.05M - - -
Other assets - - - 0.01M 0.10M
Cash 1.68M 3.20M 4.48M 0.36M 0.60M
Total current liabilities 0.71M 1.50M 0.41M 0.05M 0.04M
Net debt -1.41M -2.50M -4.48M -0.36M -0.60M
Short term debt 0.13M 0.20M - - -
Short long term debt 0.13M 0.13M 0.00M - -
Short long term debt total 0.27M 0.71M - - -
Other stockholder equity 9.78M 15.48M 2.68M 0.79M 0.65M
Property plant equipment - - 0.04M 0.01M -
Total current assets 3.58M 4.00M 4.81M 0.79M 0.61M
Net tangible assets - - 5.18M 0.74M 0.67M
Short term investments 1.53M 0.49M - - -
Net receivables 0.23M 0.04M 0.01M 0.43M 0.01M
Long term debt 0.14M 0.28M - - -
Inventory 0.06M 0.08M 0.06M 0.03M -
Accounts payable 0.16M 0.15M 0.04M 0.01M 0.01M
Accumulated other comprehensive income 2.65M - - - -
Non currrent assets other - 0.03M 0.75M - 0.10M
Non current assets total 4.78M 10.45M 0.79M 0.00M 0.10M
Capital lease obligations 0.00M 0.30M - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Investments -1.70M 0.08M -1.01M -0.30M -0.10M
Change to liabilities - - 0.12M 0.02M 0.02M
Total cashflows from investing activities -1.70M - -1.01M -0.30M -0.10M
Net borrowings -0.05M - - 0.16M 0.16M
Total cash from financing activities 2.56M 2.40M 7.24M 0.16M -0.10M
Change to operating activities - - 0.14M -0.03M -
Net income -7.99M -6.87M -4.55M -0.13M -0.36M
Change in cash -1.52M -1.27M 4.10M -0.24M -0.44M
Begin period cash flow 3.20M 4.48M 0.38M 0.60M 1.04M
End period cash flow 1.68M 3.20M 4.48M 0.36M 0.60M
Total cash from operating activities -2.52M -3.78M -2.08M -0.10M -0.35M
Issuance of capital stock 2.74M 2.47M 7.24M - 0.00M
Depreciation 1.45M 1.18M 0.01M 0.01M -
Other cashflows from investing activities -0.51M - - -0.30M -0.10M
Change to inventory 0.03M -0.02M -0.04M 0.01M -
Change to account receivables 0.02M - -0.20M -0.02M -0.02M
Other cashflows from financing activities -0.08M 0.03M 0.00M -0.30M 0.00M
Change to netincome - - 2.44M 0.03M 0.03M
Capital expenditures 0.53M 0.15M 0.04M 0.04M 0.00M
Change in working capital -0.58M 0.87M 0.02M -0.00M 0.02M
Stock based compensation 0.08M 0.97M 1.83M 0.03M -
Other non cash items 4.52M 0.07M 0.01M - -0.00M
Free cash flow -3.05M -3.93M -2.11M -0.10M -0.35M

Peer Comparison*

Sector: Healthcare Industry: Medical Care Facilities

Stock Name
Change
(GBX)
Price
(GBX)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
KNB
Kanabo Group PLC
-0.22
99.02%
0.00 - - 1.25 0.24 0.07 -2.21
CVSG
CVS Group Plc
12.00
0.92%
1316.00 50.87 12.08 1.18 2.69 1.52 9.51
SPI
Spire Healthcare Group Plc
-
-%
248.50 37.06 13.91 0.38 0.78 1.18 7.70
OHGR
One Health Group Plc
2.00
0.65%
310.00 24.09 18.15 1.06 2.75 0.75 10.53

Profile*

Kanabo Group PLC

Kanabo Group Plc, a digital health company, engages in the research, development and commercialization of cannabis-derived formulations and therapeutic inhalation devices. It operates through Primary Care and Secondary Care segments. The company offers The GP Service, an online telehealth platform, that provides patients with video consultations, online prescriptions, and primary care services; and operates Treat It, an online clinic focused on management of chronic pain. It also provides cultivation consultancy for cannabis businesses, as well as develops and distributes cannabis derived medicinal and wellness products. Kanabo Group Plc was incorporated in 2016 and is based in London, the United Kingdom.

Churchill House, London, United Kingdom, NW4 4DJ

20

Name Title Year Born
Mr. Avihu Tamir CEO & Exec. Director 1981
Mr. David Sack Co-founder NA
Mr. Assaf Vardimon Chief Financial Officer 1978
Howard Rubenstein Company Sec. NA
Mr. Avihu Tamir CEO, Executive Director & Secretary 1981
Mr. Suleman Sacranie Chief Technology Officer NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…